HomeCompareMBII vs MO

MBII vs MO: Dividend Comparison 2026

MBII yields 250.60% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MBII wins by $467.80M in total portfolio value
10 years
MBII
MBII
● Live price
250.60%
Share price
$0.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$467.88M
Annual income
$262,117,387.00
Full MBII calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — MBII vs MO

📍 MBII pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMBIIMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MBII + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MBII pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MBII
Annual income on $10K today (after 15% tax)
$21,300.59/yr
After 10yr DRIP, annual income (after tax)
$222,799,778.95/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MBII beats the other by $222,774,143.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MBII + MO for your $10,000?

MBII: 50%MO: 50%
100% MO50/50100% MBII
Portfolio after 10yr
$233.98M
Annual income
$131,073,773.08/yr
Blended yield
56.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

MBII
Analyst Ratings
5
Buy
3
Hold
Consensus: Buy
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MBII buys
0
MO buys
0
No recent congressional trades found for MBII or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMBIIMO
Forward yield250.60%6.36%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$467.88M$80.1K
Annual income after 10y$262,117,387.00$30,159.17
Total dividends collected$445.94M$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: MBII vs MO ($10,000, DRIP)

YearMBII PortfolioMBII Income/yrMO PortfolioMO Income/yrGap
1← crossover$35,760$25,059.52$10,570$780.30+$25.2KMBII
2$122,012$83,749.18$11,381$1,032.90+$110.6KMBII
3$397,612$267,058.97$12,535$1,392.73+$385.1KMBII
4$1,238,800$813,355.61$14,193$1,920.91+$1.22MMBII
5$3,693,827$2,368,311.37$16,618$2,723.68+$3.68MMBII
6$10,552,190$6,599,794.32$20,263$3,993.80+$10.53MMBII
7$28,911,115$17,620,272.02$25,936$6,098.36+$28.89MMBII
8$76,053,022$45,118,129.07$35,166$9,775.01+$76.02MMBII
9$192,299,052$110,922,318.76$51,026$16,597.78+$192.25MMBII
10$467,877,373$262,117,387.00$80,113$30,159.17+$467.80MMBII

MBII vs MO: Complete Analysis 2026

MBIIStock

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

Full MBII Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this MBII vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MBII vs SCHDMBII vs JEPIMBII vs OMBII vs KOMBII vs MAINMBII vs PMMBII vs BTIMBII vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.